BioMarin Medical Education Grant

BioMarin Medical Education Grant

Status: ACTIVE
Funder: BioMarin
Last Updated: May 28, 2025

Summary

The BioMarin Medical Education Grant offers funding for educational activities aimed at enhancing the knowledge and skills of healthcare professionals. Eligible applicants include accredited providers, medical associations, and patient advocacy groups. The grant focuses on supporting initiatives related to rare diseases, ensuring timely access to treatments and education. Applications are accepted year-round, but a minimum of 60 days is required for review prior to events. This commitment underscores BioMarin's dedication to improving patient care and advancing medical knowledge.

Overview

NOTE:  This grant is only featuring the North American Region. Funding requests are accepted for review all year. Due to BioMarin’s year-end close out activities, all requests requiring funding prior to year-end must be submitted on or before the deadline. United States (US): We ask for a minimum of 60 days prior to a given event to accommodate time for review by our committee and processing of the funding.Canada & Europe: We ask for a minimum of 60 days prior to a given event to accommodate time for review by our committee and processing of the funding. BioMarin Medical Education Grant Medical education grant funding is available for the following: Medical education activities (live, print, enduring and CME or non-CME) which serve to maintain, develop, or increase the knowledge, skills, and professional performance of healthcare professionals or patients)Fellowships or scholarships to allow an HCP-in-training to attend major scientific and educational meetings of national, regional, or specialty medical associations [review policy language] Areas of Focus BioMarin is a multinational Biotechnology company that develops and globally markets innovative therapeutics to patients with rare diseases who have serious unmet medical needs. BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes. At BioMarin, we focus on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. BioMarin remains steadfast to its original mission—to bring new treatments to market that will make a big impact on small patient populations. BioMarin is committed to patients, families, and physicians in providing rapid access to treatments, disease education, and support services. As part of its commitment, BioMarin supports programs and activities that foster excellences in patient care and provide valuable scientific, medical, and educational information to the medical and scientific communities as well as patient advocacy organizations. In alignment with BioMarin’s commitment to scientific innovation and addressing areas of unmet medical needs, BioMarin supports donations and grants in the following areas: Rare Disease (Generally) Mucopolysaccharidosis (MPS) Phenylketonuria (PKU) CLN2 (Batten Disease) Achondroplasia Hemophilia Community Relations Giving

Eligibility

You can learn more about this opportunity by visiting the funder's website. The following types of organizations are eligible to submit requests for Medical Education, Donation or Grant funding:Accredited providers Medical or professional associations Hospitals or Community Health Centers Patient Associations or Advocacy Groups Medical Education Companies Universities or Colleges Community projects or groups Registered CharitiesGrant requests for accredited activities must be submitted by an accredited provider, even if jointly sponsored by a Medical Education Company.

Ineligibility

We do not accept grant requests from individuals, including individual physicians or groups of physicians in private practice.Per company policy, where funding is requested for a specific event or activity, BioMarin is unable to accept the request where the program date has passed.BioMarin will deny, without consideration, any grant request submitted by an organization named on a debarment or exclusion list, including, but not limited to, the U.S. Office of Inspector General’s List of Excluded Individuals/Entities (OIG LEIE) or the U.S. General Services Administration Excluded Parties List System (GSA EPLS).